Search for: "K-V Pharmaceutical Company"
Results 1 - 20
of 225
Sort by Relevance
|
Sort by Date
12 Mar 2024, 2:48 am
Under no circumstances,’ underlines judge Kūris in his elaborated dissenting opinion in Mesić v. [read post]
Celanese v. ITC: Can a Secret Manufacturing Process Be Patented After Sale of the Resulting Product?
4 Mar 2024, 9:45 am
Auld Company v. [read post]
25 Jan 2024, 5:31 am
Crude oil contains metals such as Cadmium (Cd), Lead (Pb), Manganese (Mn), Nickel (Ni), and Vanadium (V). [read post]
2 Jan 2024, 12:56 pm
Thus, by my tally there were 25 securities class action lawsuits filed against companies in the 283 SIC Code Industry Group (Drugs), including 17 in the 2834 SIC Code category (Pharmaceutical Preparations). [read post]
13 Nov 2023, 5:40 pm
Through corrupt bidding, the official can award the contract to a company, even though the company did not place the lowest bid. [read post]
11 Oct 2023, 1:23 am
Hoffmann-La Roche AG together with Chugai Pharmaceutical Co. [read post]
30 May 2023, 11:54 am
The case involves Vital Pharmaceuticals, which markets “performance energy drinks” a/k/a drinks that accelerate your death. [read post]
10 Apr 2023, 9:01 pm
At the close of business on Good Friday, federal judge Matthew Kacsmaryk released a ruling in Alliance for Hippocratic Medicine vs. [read post]
3 Jan 2023, 1:47 pm
By my count, 21 of the 54 SPAC-related lawsuits filed since January 1, 2021 were filed following the publication of a short-seller report critical of the SPAC merger or the target company. [read post]
19 Dec 2022, 4:00 pm
Litig. v. [read post]
15 Jul 2022, 10:09 am
Mousavi I, Olivier T, Prasad V. [read post]
11 Jul 2022, 9:05 pm
V. 2014. [read post]
19 Apr 2022, 5:05 am
United States v. [read post]
20 Sep 2021, 1:23 am
Cir. 2012); Adverio Pharma GmbH v. [read post]
26 Jul 2021, 10:57 pm
Pharma Expressz appealed the decision, refusing marketing authorisation, to the Fővárosi Törvényszék (Budapest High Court, Hungary). [read post]
13 Jul 2021, 10:58 am
Likewise, setting adequate compensation, as required under TRIPS Article 31(h) has never been predictable or easily administered.[15] Additionally, and of similar importance, other questions remain outstanding, including which countries qualify for parallel imports,[16] navigating the complexities of licensing agreements,[17] ensuring timeliness during public health emergencies,[18] and achieving cooperation from pharmaceutical companies who arguably have little incentive to… [read post]
30 Jun 2021, 3:35 pm
Lance, of course, relied on § 6(c) of the Restatement (Third) of Torts—that “pharmaceutical companies violate their duty of care if they introduce a drug into the marketplace, or continue a previous tender, with actual or constructive knowledge that the drug is too harmful to be used by anyone. [read post]
4 Jan 2021, 1:26 pm
-listed companies. [read post]
1 Dec 2020, 7:41 am
Defendants deny all allegations of wrongdoing or liability whatsoever, (Rabkin v. [read post]
20 Nov 2020, 5:00 am
First, in Silverstrand Investments v. [read post]
